Ikeda, Japan

Motoji Kawasaki

This inventor holds 3 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoji Kawasaki. Retrieved from https://idiyas.com/inventor/motoji-kawasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Motoji Kawasaki: Innovator in Pharmaceutical Chemistry

Introduction

Motoji Kawasaki is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development of innovative compounds that have potential applications in medicine.

Latest Patents

Kawasaki's latest patents include a series of inventions related to 2,3-disubstituted pyridine derivatives. These patents detail a process for the preparation of these derivatives, as well as pharmaceutical compositions containing them. The innovative nature of these compounds highlights Kawasaki's commitment to advancing pharmaceutical science.

Career Highlights

Motoji Kawasaki is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on the industry.

Collaborations

Throughout his career, Kawasaki has collaborated with talented individuals such as Tomohiro Nigo and Tadashi Nobata. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Motoji Kawasaki is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in the field. His contributions continue to influence the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…